ArticleAllergy, asthma & immunology research2024

Long-term Safety and Efficacy of Dupilumab in Patients With Uncontrolled, Moderate-to-Severe Asthma Recruited From Korean Centers: A Subgroup Analysis of the Phase 3 LIBERTY ASTHMA TRAVERSE Trial.

Chin Kook Rhee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.